111 related articles for article (PubMed ID: 16380982)
1. Combined therapy of an established, highly aggressive breast cancer in mice with paclitaxel and a unique DNA-based cell vaccine.
Chopra A; Kim TS; O-Sullivan I; Martinez D; Cohen EP
Int J Cancer; 2006 Jun; 118(11):2888-98. PubMed ID: 16380982
[TBL] [Abstract][Full Text] [Related]
2. Enhanced immunity to breast cancer in mice immunized with fibroblasts transfected with a complementary DNA expression library from breast cancer cells: Enrichment of the vaccine for immunotherapeutic cells.
Kim TS; Chopra A; O-Sullivan IS; Cohen EP
J Immunother; 2006; 29(3):261-73. PubMed ID: 16699369
[TBL] [Abstract][Full Text] [Related]
3. Immunogene therapy.
Lichtor T; Glick RP
Adv Exp Med Biol; 2012; 746():151-65. PubMed ID: 22639166
[TBL] [Abstract][Full Text] [Related]
4. Immunity to breast cancer in mice immunized with fibroblasts transfected with a cDNA expression library derived from small numbers of breast cancer cells.
Sung Kim T; Cohen EP
Cancer Gene Ther; 2005 Nov; 12(11):890-9. PubMed ID: 15905859
[TBL] [Abstract][Full Text] [Related]
5. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
Kim TS; Jung MY; Cho D; Cohen EP
Vaccine; 2006 Oct; 24(42-43):6564-73. PubMed ID: 16837111
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
O-Sullivan I; Kim TS; Chopra A; Cohen EP
Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
[TBL] [Abstract][Full Text] [Related]
7. Immunity to growth factor receptor-bound protein 10, a signal transduction molecule, inhibits the growth of breast cancer in mice.
O-Sullivan I; Chopra A; Carr J; Kim TS; Cohen EP
Cancer Res; 2008 Apr; 68(7):2463-70. PubMed ID: 18381455
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin and paclitaxel enhance the antitumor efficacy of vaccines directed against HER 2/neu in a murine mammary carcinoma model.
Eralp Y; Wang X; Wang JP; Maughan MF; Polo JM; Lachman LB
Breast Cancer Res; 2004; 6(4):R275-83. PubMed ID: 15217493
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer.
Lichtor T; Glick RP; Lin H; O-Sullivan I; Cohen EP
Cancer Gene Ther; 2005 Aug; 12(8):708-14. PubMed ID: 15803143
[TBL] [Abstract][Full Text] [Related]
10. Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer.
Kim JH; Majumder N; Lin H; Chen J; Falo LD; You Z
Mol Ther; 2005 Jun; 11(6):941-9. PubMed ID: 15922965
[TBL] [Abstract][Full Text] [Related]
11. Treatment of squamous carcinoma in mice with a vaccine enriched for cells that induce immunity to squamous carcinoma--a new vaccination strategy.
Chopra A; Kim TS; O-Sullivan I; Martinez D; Cohen EP
Int J Cancer; 2006 Jul; 119(2):339-48. PubMed ID: 16477635
[TBL] [Abstract][Full Text] [Related]
12. Enhanced immunity to intracerebral breast cancer in mice immunized with a cDNA-based vaccine enriched for immunotherapeutic cells.
Lichtor T; Glick RP; Feldman LA; Osawa G; Hardman J; O- Sullivan I; Cohen EP
J Immunother; 2008 Jan; 31(1):18-27. PubMed ID: 18157008
[TBL] [Abstract][Full Text] [Related]
13. Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells.
de Zoeten E; Carr-Brendel V; Markovic D; Taylor-Papadimitriou J; Cohen EP
J Immunol; 1999 Jun; 162(11):6934-41. PubMed ID: 10352316
[TBL] [Abstract][Full Text] [Related]
14. Low-dose paclitaxel enhances the anti-tumor efficacy of GM-CSF surface-modified whole-tumor-cell vaccine in mouse model of prostate cancer.
He Q; Li J; Yin W; Song Z; Zhang Z; Yi T; Tang J; Wu D; Lu Y; Wang Z; Liu D; Zhang X; Hu Z; Gao J
Cancer Immunol Immunother; 2011 May; 60(5):715-30. PubMed ID: 21331814
[TBL] [Abstract][Full Text] [Related]
15. In vivo responses to vaccination with Mage-b, GM-CSF and thioglycollate in a highly metastatic mouse breast tumor model, 4T1.
Gravekamp C; Leal B; Denny A; Bahar R; Lampkin S; Castro F; Kim SH; Moore D; Reddick R
Cancer Immunol Immunother; 2008 Jul; 57(7):1067-77. PubMed ID: 18094967
[TBL] [Abstract][Full Text] [Related]
16. Cancer therapy with DNA-based vaccines.
Cohen EP
Immunol Lett; 2000 Sep; 74(1):59-65. PubMed ID: 10996629
[TBL] [Abstract][Full Text] [Related]
17. Enrichment of a squamous carcinoma vaccine.
O-Sullivan I; Chopra A; Cohen EP
Drug News Perspect; 2007 Mar; 20(2):95-101. PubMed ID: 17440632
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
19. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21.
Yamano T; Kaneda Y; Hiramatsu SH; Huang S; Tran AN; Giuliano AE; Hoon DS
Cancer Gene Ther; 2007 May; 14(5):451-9. PubMed ID: 17318199
[TBL] [Abstract][Full Text] [Related]
20. Enhanced paclitaxel cytotoxicity and prolonged animal survival rate by a nonviral-mediated systemic delivery of E1A gene in orthotopic xenograft human breast cancer.
Liao Y; Zou YY; Xia WY; Hung MC
Cancer Gene Ther; 2004 Sep; 11(9):594-602. PubMed ID: 15272313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]